Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $781 billion, total revenue of $166.47 billion and a weighted average PE ratio of 52.22.
Market Cap
781B
Revenue
166.47B
Profits
14.96B
PE Ratio
52.22
Profit Margin
8.98%
Dividend Yield
0.18%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 213.82B | -0.19% | 627,640 | 43.74B |
| 2 | DHR | Danaher Corporation | 159.14B | 0.27% | 388,393 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 56.03B | 1.23% | 76,900 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 39.05B | -0.89% | 348,648 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 38.17B | 1.11% | 198,421 | 15.90B |
| 6 | NTRA | Natera, Inc. | 31.16B | -0.93% | 149,196 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.53B | 0.73% | 12,243 | 3.94B |
| 8 | WAT | Waters Corporation | 22.68B | 0.64% | 54,139 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 21.37B | -0.13% | 111,032 | 13.77B |
| 10 | ILMN | Illumina, Inc. | 20.17B | 0.33% | 223,830 | 4.29B |
| 11 | DGX | Quest Diagnostics Incorporated | 19.91B | 0.17% | 83,105 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.32B | 0.06% | 1,293,699 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.82B | 0.51% | 20,353 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 13.92B | -0.10% | 67,411 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 12.68B | -1.59% | 236,834 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 11.14B | 2.10% | 448,303 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 9.85B | 0.91% | 312,994 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 9.76B | 1.56% | 78,668 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.56B | 1.20% | 191,365 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.79B | 0.96% | 101,790 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.21B | - | 4,860 | 254.14M |
| 22 | WGS | GeneDx Holdings Corp. | 4.12B | 0.59% | 15,013 | 402.19M |
| 23 | VCYT | Veracyte, Inc. | 3.38B | -1.06% | 102,562 | 495.14M |
| 24 | GRAL | GRAIL, Inc. | 3.35B | -1.13% | 116,786 | 141.83M |
| 25 | TWST | Twist Bioscience Corporation | 2.00B | 4.91% | 371,873 | 376.57M |
| 26 | NEOG | Neogen Corporation | 1.54B | 0.99% | 357,886 | 886.89M |
| 27 | NEO | NeoGenomics, Inc. | 1.50B | -0.94% | 149,301 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.15B | 1.00% | 34,885 | 343.53M |
| 29 | CDNA | CareDx, Inc | 1.01B | 1.86% | 187 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 1.00B | -0.38% | 446,101 | 642.07M |
| 31 | FLGT | Fulgent Genetics, Inc. | 852.72M | 1.56% | 23,508 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 714.88M | 0.88% | 137,858 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 655.29M | 2.18% | 158,125 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 267.57M | -4.10% | 24,091 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 213.29M | 5.71% | 39,114 | 75.75M |
| 36 | MDXH | MDxHealth SA | 159.88M | -3.87% | 63,666 | 103.07M |
| 37 | XGN | Exagen Inc. | 151.84M | -0.74% | 51,637 | 63.60M |
| 38 | IMDX | Insight Molecular Diagnostics Inc. | 146.19M | - | 3,145 | 4.40M |
| 39 | FONR | FONAR Corporation | 94.34M | 0.35% | 11,150 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 63.33M | 0.76% | 3,075 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 43.13M | 2.50% | 2,253 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 21.82M | -6.54% | 184,937 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 10.48M | -1.03% | 16,147 | - |
| 44 | MYNZ | Mainz Biomed N.V. | 8.84M | 3.00% | 126,448 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 8.37M | -0.31% | 14,110 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 6.22M | 0.36% | 7,344 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 5.72M | -0.81% | 10,090 | - |
| 48 | PRPH | ProPhase Labs, Inc. | 5.61M | 5.65% | 705,078 | 5.06M |
| 49 | XWEL | XWELL, Inc. | 4.27M | 1.83% | 1 | 29.52M |
| 50 | ISPC | iSpecimen Inc. | 3.86M | -3.28% | 53,055 | 3.35M |